|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 241 - 250 of 441:
FDA Approves Continuous 7-Day Glucose Monitoring System
The U.S. Food and Drug Administration today approved a device that measures glucose levels continuously for up to seven days in people with diabetes.W...
Avalere Health Compares FDA Review of Several Categories of Drugs Including Alzheimer's Disease
There are noticeable differences in the way the FDA reviews potential Alzheimer's disease (Alzheimer's), HIV/AIDS, and cancer therapies, says a new an...
Sage Communications Launches New Healthcare and Health/IT Division
Sage Communications, one of the fastest growing full-service marketing communications firms in Washington D.C., announced the launch of its new Health...
Shelhigh: FDA Refuses to Disclose Facts
The FDA continued its attack against Shelhigh by releasing a newscast on its website this month, again promoting its unfounded allegations against the...
FDA Approves Norditropin for Treatment Of Short Stature Associated With A Rare Genetic Disorder
Novo Nordisk announced that Norditropin (somatropin[rDNA origin] injection)received U.S. Food and Drug Administration (FDA) approval for the treatment...
FDA Approves Norditropin for Treatment Of Short Stature Associated With A Rare Genetic Disorder
Novo Nordisk announced that Norditropin (somatropin[rDNA origin] injection)received U.S. Food and Drug Administration (FDA) approval for the treatment...
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
Mylan Laboratories announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its ...
Dendreon Announces FDA Confirms Data Required for Provenge(R) Licensure
Dendreon Corporation announced the Company has received confirmation that the U.S. Food and Drug Administration (FDA) will accept either a positive in...
FDA Approves New Drug for Advanced Kidney Cancer
The U.S. Food and Drug Administration (FDA) today approved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known ...
FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Critical Therapeutics, DEY Marketing Partner for Chronic Treatment of Asthma
Dey announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) of its marketing partner, Critical Therapeu... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |